Showing results (121-130 of 253) with videos related to
Sort By:
Pageof 26
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 30, 1999
Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. Swiss HIV Cohort StudyP P Sendi, H C Bucher, B A Craig, et al.Schweizerische Medizinische Wochenschrift|December 28, 1996
[Sex differences in disease course: analysis of the Swiss HIV cohort study]M Schmid, W Twisselmann, B J Jacquat, et al.BJU International|October 6, 1999
Treatment for human immunodeficiency virus with indinavir may cause relevant urological side-effects, effectively treatable by rehydrationB Hug, M Naef, H C Bucher, et al.Praxis|February 20, 1999
[Quality aspects in internal medicine--from anamnesis to meta-analysis]M Battegay, B Martina, B Bucheli, et al.European Journal of Clinical Investigation|January 1, 1994
Circulating somatostatin-28 is not a physiologic regulator of gastric acid production in manP Hildebrand, J W Ensinck, J Buettiker, et al.Journal of Virology|July 1, 1994
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient miceM Battegay, D Moskophidis, A Rahemtulla, et al.European Journal of Gastroenterology & Hepatology|March 26, 1998
Genotype distribution of hepatitis C virus infection in Greece: correlation with different risk factors and response to interferon therapyI Diamantis, I Vafiadis, E Voskaridou, et al.Drug and Alcohol Dependence|July 27, 2001
Onset and pattern of substance use in intravenous drug users of an opiate maintenance programC Zinkernagel, M R Naef, H C Bucher, et al.AIDS (London, England)|June 6, 2000
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort StudyN Khanna, T Klimkait, V Schiffer, et al.Swiss Medical Weekly|January 7, 2005
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infectionT Wagels, R Amiet, M Battegay, et al.Pageof 26